Product Information
Contents: Allophycocyanin (APC) anti-mouse TACI (CD267)
Catalog Number: 17-5942
Sizes: 50 ug, 100 ug
Formulation: Phosphate buffered saline, pH 7.2, less than or equal to 0.09% NaN3
Storage Conditions: Store at 4°C. DO NOT FREEZE. LIGHT-SENSITIVE MATERIAL.
Clone: ebio8F10-3
Isotype: Rat IgG2a, κ
|
|
Staining of C57Bl/6 bone marrow cells with FITC anti-mouse CD19 (1D3) (cat. 11-0193) and 0.125 μg of APC Rat IgG2a Iso Cntrl (cat. 17-4321) (left) or 0.125 μg of APC anti-mouse TACI (ebio8F10-3) (right). Cells in the lymphocyte gate were used for analysis.
|
Questions? Please consult our answers to frequently asked questions at
http://www.ebioscience.com/faq.
Description
The monoclonal antibody eBio8F10.3 recognizes TACI (Transmembrane Activator and Calcium-modulator and CAML Interactor) also known as CD267. TACI is a type III membrane protein belonging to the TNF receptor superfamily. The ligand for TACI has been shown to be BAFF (BLyS) and APRIL. TACI is expressed on the surface of a subset of maturing splenic B cells of the transitional type termed T2. Genetic studies have shown a role for TACI in both stimulation and inhibition of B cell proliferation. This actual role for TACI in the mouse has still not been determined. Recently human TACI has been shown to have repressive activities which inhibit BAFF-R function.
Applications Reported
For research use only, not for diagnostic or therapeutic use. This ebio8F10-3 antibody has been reported for use in flow cytometric analysis.
Applications Tested
This ebio8F10-3 antibody has been tested by flow cytometric analysis of mouse splenocytes. This can be used at less than or equal to 0.25 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
References
Batten M, Fletcher C, Ng LG, Groom J, Wheway J, Laabi Y, Xin X, Schneider P, Tschopp J, Mackay CR, Mackay F. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.
J Immunol. 2004 Jan 15;172(2):812-22 (8F10-3,
PubMed)
Diaz-de-Durana Y, Mantchev GT, Bram RJ, Franco A. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.
Blood. 2006 Jan 15;107(2):594-601. Epub 2005 Sep 29. (8F10-3, FC
PubMed).
Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, Thompson JS, Wheway J, Chtanova T, Groom J, Sutton IJ, Xin C, Tangye SG, Kalled SL, Mackay F, Mackay CR. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells.
J Immunol. 2004 Jul 15;173(2):807-17 (8F10-3,
PubMed).
Related Products
Cat. 12-0193 Phycoerythrin (PE) anti-mouse CD19 (clone eBio1D3 (1D3))Cat. 17-4321 APC Rat IgG2a Isotype ControlCat. 11-5943 Fluorescein isothiocyanate (FITC) anti-mouse BAFF R (BR3, CD268, BLyS receptor 3, BAFF-R, BAFF Receptor) (clone eBio7H22-E16)